Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)

Clinical trial NCT07404345 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07404345
Sponsor: Hospital Civil de Guadalajara
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hemodialysis Access Failure Kidney Disease, End-Stage Hemodialysis Catheter

Start date: 2026-03-01
Primary completion: 2028-03-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.